Zhende Medical Co., Ltd.
603301
Rang in Aktien
#4841
Zhende Medical Co., Ltd. engages in the research and development, production,... Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pad and applicator; and gauze roll and abdominal pad. It also provides surgical gown, scrub suit, warm-up jacket, surgical headwear, and isolation gown; Surgical drape; standard surgical pack and custom procedure pack; equipment cover; OP Tape, hand towel, and fluid collection pouch; latex surgical glove; CSR wrap; and warming blanket system. In addition, the company offers isolation gown, surgical cap, shoe cover, medical mask, and particular respirator; compression bandage and compression stocking; wound care products; pre-filled flush syringes; and ostomy and accessories. Further, it provides respiratory health, home cleaning, IP collaboration, nasal care, protective gear and assistive devices, and personal beauty products. Zhende Medical Co., Ltd. was incorporated in 1994 and is headquartered in Shaoxing, China.
Aktienkurs
$11.60
Marktkapitalisierung
$3.06B
Veränderung (1 Tag)
2.99%
Veränderung (1 Jahr)
14.73%
Land
CN
Handel Zhende Medical Co., Ltd. (603301)
Kategorie
Healthcare
Gewinn für Zhende Medical Co., Ltd. (603301)
Gewinn im Jun 2026 TTM: $49.34M
Laut den aktuellen Finanzberichten von Zhende Medical Co., Ltd. betragen die aktuellen Gewinne des Unternehmens $49.34M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $30.92M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $116.23M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Zhende Medical Co., Ltd. von 2014 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $49.34M | -24.26% |
| 2024 | $65.14M | 110.65% |
| 2023 | $30.92M | -73.39% |
| 2022 | $116.23M | -9.91% |
| 2021 | $129.01M | -76.15% |
| 2020 | $540.83M | 1,790.20% |
| 2019 | $28.61M | 29.86% |
| 2018 | $22.03M | -2.72% |
| 2017 | $22.65M | 57.83% |
| 2016 | $14.35M | 2.07% |
| 2015 | $14.06M | 258.39% |
| 2014 | $3.92M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $3.81B | 7,613.63% |
US
|
|
| $4.11B | 8,227.84% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 3,122.63% |
US
|
|
| - | - |
CH
|
